Millipore Sigma Vibrant Logo
Attention: We have moved. Merck Millipore products are no longer available for purchase on MerckMillipore.com.Learn More

MABF2820-100UG Anti-HCV E2 Antibody, clone AP33

MABF2820-100UG
100 μg  
Purchase on Sigma-Aldrich

Áttekintés

Replacement Information
Description
Catalogue NumberMABF2820-100UG
DescriptionAnti-HCV E2 Antibody, clone AP33
Alternate Names
  • HCV envelope glycoprotein E2
Background InformationGenome polyprotein (UniProt: P27958) is encoded by the POLY gene (Gene ID: 951475) in Hepatitis C virus. HCV is a small (~55-65 nm), enveloped, positive-sense single-stranded RNA virus that is a causative factor for hepatitis C and hepatocellular carcinoma. HCV expresses several proteins that promote viral replication. Genome polyprotein of HCV can be cleaved into 11 different chains. The mature core protein packages viral RNA to form a viral nucleocapsid and promotes virion budding. It also prevents the establishment of cellular antiviral state by blocking the interferon- /β and interferon- signaling pathways and by inducing STAT1 degradation. Envelope proteins E1 and E2 that form a heterodimer are heavily glycosylated and are involved in virus attachment to the host cell, virion internalization through clathrin-dependent endocytosis and fusion with host membrane. In HCV, Viroprotein P7, a heptameric ion channel protein, plays an essential role in the assembly, envelopment, and secretion of viral particles. It also contains NS2, a cysteine protease and NS3, a serine protease. NS2 is required for the proteolytic auto-cleavage between NS2 and NS3. NS3 binds a single ATP and catalyzes the unzipping of a single base pair of dsRNA. Non-structural protein 4A (NS4A), a peptide cofactor, forms a non-covalent complex with the N-terminal of NS3 and this complex prevents phosphorylation of host IRF3, which also prevents the establishment of dsRNA induced antiviral state. NS4B induces a specific membrane alteration that serves as a scaffold for the virus replication complex. Non-structural protein 5A (NS5A), a multi-functional phosphoprotein, is an RNA-binding peripheral membrane protein that is reported to antagonize numerous cellular pathways, including the antiviral interferon-a response. NS5A exists as hypo- and hyper-phosphorylated forms and the dynamic transition between these two states is involved in the functions of NS5A. Hyperphosphorylation occurs primarily at its six serine residues within the low complexity sequence of NS5A. Phosphorylated NS5A is shown to be essential for viral replication and assembly. Clone AP33 recognizes an epitope within the N-terminal portion of the E2 ectodomain (aa 412 to 423). It is shown to inhibit the interaction of truncated E2 (E2(660)), full-length E1E2 complex expressed in mammalian cells, and of HCV virus-like particles with CD81. It also displays potent neutralizing activity against HCV carrying E1E2 of all genotypes. (Ref.: Owsianka, A., et al. (2005). J. Virol. 79(17); 11095-11104; Clayton, RF., et al. (2002). J. Virol. 76(15); 7672-7682; Owsianka, A., et al. (2001). J. Gen. Virol. 82(8); 1877-1883).
References
Product Information
FormatPurified
PresentationPurified mouse monoclonal antibody IgG1 in PBS without azide.
Quality LevelMQ200
Applications
ApplicationAnti-HCV E2, clone AP33, Cat. No. MABF2820, is a mouse monoclonal antibody that detects envelope protein E2 in HCV and is tested in ELISA, Electron Microscopy, Function Analysis, Immunoprecipitation, Inhibition Assay, Neutralizing, and Western Blotting.
Key Applications
  • Western Blotting
  • Electron Microscopy
  • ELISA
  • Inhibition
  • Affects Function
  • Neutralizing
  • Immunoprecipitation
Application NotesTested applications

Inhibition: A representative lot Inhibited the interaction of virus-like particles (VLPs) with CD81 and inhibited infection by HCVpp of diverse genotypes.(Owsianka, A., et al. (2001). J Gen Virol. 82(Pt8):1877-1883; Owsianka, A., et al. (2005). J Virol. 79(17):11095-104).

ELISA: A representative lot detected HCV E2 in ELISA application. (Owsianka, A., et al. (2005). J Virol. 79(17):11095-104; Rychlowska, M., et al. (2011). J Gen Virol. 92(Pt10)2249-2261; Vasiliauskaite, I., et al. (2017). mBio. 8(3):e00382-17).

Electron Microscopy: A representative lot detected virus like particles of HCV in Electron Cryomicroscopy application (Owsianka, A., et al. (2001). J Gen Virol. 82(Pt8):1877-1883; Clayton, R.F., et al. (2002). J Virol. 76(15):7672-82).

Western Blotting Analysis: A representative lot detected HCV E2 in Western Blotting application (Clayton, R.F., et al. (2002). J Virol. 76(15):7672-82; Rychlowska, M., et al. (2011). J Gen Virol. 92(Pt10)2249-2261; Hu, Z., et al. (2020). Cell Chem Biol. 27(7):780-792.e5).

Immunoprecipitation Analysis: A representative lot immunoprecipitated HCV E2 in Immunoprecipitation application (Owsianka, A., et al. (2005). J Virol. 79(17):11095-104).

Neutralizing: A representative lot neutralized HCV infection across all major genotypes of HCV (Owsianka, A., et al. (2005). J Virol. 79(17):11095-104; Potter, J.A., et al. (2012). J Virol. 86(23):12923-32).

Note: Actual optimal working dilutions must be determined by end user as specimens, and experimental conditions may vary with the end user.
Biological Information
ImmunogenHis-tagged recombinant form of mammalian cell-expressed HCV strain Gla E1E2 emulsified in Freund's complete adjuvant.
EpitopeN-terminal half
CloneAP33
Concentration1.0 mg/mL. Please refer to guidance on suggested starting dilutions and/or titers per application and sample type.
HostMouse
SpecificityClone AP33 is a mouse monoclonal antibody that detects envelope glycoprotein E2. It targets an epitope within 12 amino acids from the N-terminal half.
IsotypeIgG1κ
Species Reactivity
  • Virus
Species Reactivity NoteHepatitis C virus.
Antibody TypeMonoclonal Antibody
Entrez Gene Number
Gene Symbol
  • E2
Purification MethodProtein G purified
UniProt Number
Molecular Weight~60 kDa observed; 327.15 kDa for the full-length Genome Polyprotein. Uncharacterized bands may be observed in some lysate(s).
Physicochemical Information
Dimensions
Materials Information
Toxicological Information
Safety Information according to GHS
Safety Information
Product Usage Statements
Quality AssuranceEvaluated by Western Blotting in lysate from HEK293T cells transfected with a plasmid expressing the HCV E1 and E2 glycoproteins.

Western Blotting Analysis: A 1:1,000 dilution of this antibody detected HCV E2 in lysate from HEK293T cells transfected with a plasmid expressing the HCV E1 and E2 glycoproteins, but not in lysates from untransfected cells.
Usage Statement
  • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
Storage and Shipping Information
Storage ConditionsStore at -10°C to -25°C. Handling Recommendations: Upon receipt and prior to removing the cap, centrifuge the vial and gently mix the solution. Aliquot into microcentrifuge tubes and store at -20°C. Avoid repeated freeze/thaw cycles, which may damage IgG and affect product performance.
Packaging Information
Material Size100 μg
Transport Information
Supplemental Information
Specifications
Global Trade Item Number
Katalógusszám GTIN
MABF2820-100UG 04065269135050

Documentation

Anti-HCV E2 Antibody, clone AP33 MSDS

Title

Safety Data Sheet (SDS) 

Anti-HCV E2 Antibody, clone AP33 Certificates of Analysis

TitleLot Number
Anti-HCV E2, clone AP33 - 4095808 4095808
Anti-HCV E2, clone AP33 - 4097814 4097814
Anti-HCV E2, clone AP33 - 4098473 4098473
Anti-HCV E2, clone AP33 - 4122557 4122557
Anti-HCV E2, clone AP33 - 4128215 4128215
Anti-HCV E2, clone AP33 - 4148786 4148786
Anti-HCV E2, clone AP33 - 4156358 4156358
Anti-HCV E2, clone AP33 - 4195070 4195070
Anti-HCV E2, clone AP33 - Q3955674 Q3955674